Key Facts
• August 2025: US announces 39% tariff on Swiss imports, shocking Swiss businesses.
• Ypsomed CEO Simon Michel plans partial production shift to Germany, with lower tariffs.
• Swiss government negotiates tariff reduction but faces limited alternatives to US market.
• Nestlé’s Nespresso production remains in Switzerland, highlighting challenges for local firms.
• Machine tool maker Netstal Maschinen considers reducing Swiss-made components for US exports.
• Swatch pre-shipped inventory to the US, citing competitive advantage in stock availability.
• Swiss exports to the US saw a slight increase, per logistics firm Kuehne + Nagel.
• Tariffs could reduce Swiss GDP by 1% and threaten thousands of domestic jobs.
• Pharmaceutical giants Roche and Novartis currently exempt but face potential future tariffs.
• Trump administration hints at extending tariffs to pharmaceuticals next week.
Summary
The US’s sudden imposition of a 39% tariff on Swiss imports has left Swiss companies scrambling to adapt. Ypsomed plans to shift some production to Germany, while other firms like Nestlé and Swatch are taking measures such as pre-shipping inventory or exploring supply chain adjustments. The Swiss government is negotiating for tariff reductions, but businesses acknowledge the irreplaceability of the US market. The tariffs are expected to reduce Switzerland’s GDP by 1% and jeopardize thousands of jobs, particularly in small and medium-sized enterprises. While some sectors, like pharmaceuticals, remain exempt for now, the Trump administration has signaled potential future tariffs on these products, adding to the uncertainty.
